Literature DB >> 7080318

Transitional cell carcinoma of renal pelvis.

B N Nocks, N M Heney, J J Daly, T A Perrone, P P Griffin, G R Prout.   

Abstract

Sixty-eight patients with transitional cell carcinoma of the renal pelvis were studied with respect to clinical presentation, tumor grade, stage and location, subsequent development of other urothelial tumors, and patient survival. Of the 66 patients with adjacent mucosa available for evaluation, 63 (95 per cent) had abnormal findings with severe dysplasia and CIS common in the high-grade, high-stage tumors. Twenty-eight patients (41 per cent) had transitional cell carcinoma previously, concomitantly, and/or subsequently, and in 14 patients (21 per cent) subsequent bladder tumors developed. Because of the relatively high tumor recurrence rate in the ureter (16 per cent) in patients who underwent subtotal ureterectomies, nephrectomy and complete ureterectomy including a bladder cuff should be the operation of choice in patients with carcinoma of the renal pelvis.

Entities:  

Mesh:

Year:  1982        PMID: 7080318     DOI: 10.1016/0090-4295(82)90601-x

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  9 in total

1.  Scanning electron microscopy of the upper urinary tract in transitional cell carcinoma of the renal pelvis.

Authors:  J Newman; G N Antonakopoulos; R M Hicks
Journal:  Br J Exp Pathol       Date:  1988-08

2.  Diagnosis easily missed--upper urothelial tumour.

Authors:  G R Mufti; J S Virdi
Journal:  Postgrad Med J       Date:  1988-09       Impact factor: 2.401

3.  Treatment of upper tract urothelial carcinoma: a review of surgical and adjuvant therapy.

Authors:  Kalyan C Latchamsetty; Christopher R Porter
Journal:  Rev Urol       Date:  2006

4.  Two-micron thulium laser resection of the distal ureter and bladder cuff during nephroureterectomy for upper urinary tract urothelial carcinoma.

Authors:  Kun Pang; Shi-bo Liu; Hai-bin Wei; Jian Zhuo; Mei-li Li; Shu-jie Xia; Xiao-wen Sun
Journal:  Lasers Med Sci       Date:  2013-06-23       Impact factor: 3.161

5.  Results of adjuvant chemotherapy for invasive uroepithelial cancer.

Authors:  Y Uekado; A Hirano; T Shinka; T Ohkawa
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

6.  p53 and H-ras mutations and microsatellite instability in renal pelvic carcinomas of NON / Shi mice treated with N-butyl-N-(4-hydroxybutyl)-nitrosamine: different genetic alteration from urinary bladder carcinoma.

Authors:  H Gen; S Yamamoto; K Morimura; W Min; M Mitsuhashi; T Murai; S Mori; M Hosono; T Oohara; S Makino; H Wanibuchi; S Fukushima
Journal:  Jpn J Cancer Res       Date:  2001-12

7.  Comparative analysis of patients with upper urinary tract urothelial carcinoma in black-foot disease endemic and non-endemic area.

Authors:  Che-Wei Chang; Chien-Hui Ou; Chih-Chin Yu; Chi-Wen Lo; Chung-You Tsai; Pai-Yu Cheng; Yung-Tai Chen; Hsu-Che Huang; Chia-Chang Wu; Ching-Chia Li; Hsiang-Ying Lee
Journal:  BMC Cancer       Date:  2021-01-19       Impact factor: 4.430

8.  Comprehensive management of upper tract urothelial carcinoma.

Authors:  Georgios Koukourakis; Georgios Zacharias; Michael Koukourakis; Kiriaki Pistevou-Gobaki; Christos Papaloukas; Athanasios Kostakopoulos; Vassilios Kouloulias
Journal:  Adv Urol       Date:  2008-12-10

9.  Renal pelvic carcinoma which shows metastatic potential to distant organs, induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in NON/Shi mice.

Authors:  T Murai; S Mori; M Hosono; Y Takeuchi; T Ohara; S Makino; R Takeda; Y Hayashi; S Fukushima
Journal:  Jpn J Cancer Res       Date:  1991-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.